Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,121 total articles
Director Ciesla Craig reported the sale of 11,000 Lightwave Logic, Inc. (NASDAQ:LWLG) shares on April 1, 2026, in a Form 4 filing. The shares, sold at $6.81 to $6.831, totaled $74,910 and were sold to satisfy tax withholding related to RSU vestings on March 31, 2026. After the sale Craig holds 118,824 shares. The insider transaction arrives as LWLG…
Japan Post Holdings Co., Ltd. sold 21,500 shares of Aflac Inc. (NYSE: AFL) on April 6, 2026, in two transactions that generated $2,372,267 in proceeds. The trades were transacted by J&A Alliance Holdings Corporation as trustee of the J&A Alliance Trust. After the sale Japan Post indirectly holds 51,913,300 Aflac shares. The transaction coincides wi…
Stuart Naylor, Chief Development Officer at MeiraGTx Holdings PLC (NASDAQ:MGTX), sold 27,661 ordinary shares on April 7, 2026, for $258,906 at a weighted average price of $9.36. The transaction was made under a Rule 10b5-1 trading plan adopted on December 9, 2025. The stock is trading near a 52-week high amid positive regulatory and partnering deve…
Indie Semiconductor Chief Operating Officer Michael Wittmann sold 4,720 Class A shares on April 6 for $2.9861 each, netting $14,094, while retaining a direct stake of 137,954 shares. The company disclosed a separate Restricted Stock Unit exercise that yielded 12,539 shares with a reported value of $0 on April 3. Indie also announced a new ultraviol…
EverQuote reported a modest insider sale by Chief Accounting Officer Ayotte Jon on April 6, 2026, disposing of 364 Class A shares for $5,587 under a Rule 10b5-1 plan. The transaction comes after robust fourth-quarter 2025 results but amid lowered analyst price targets and expectations that insurance carriers will pull back on early-2026 marketing s…
Ichiro Aoki, president of indie Semiconductor, sold 3,506 Class A shares at $2.9862 per share on April 6, 2026, totaling $10,469. Earlier, on April 3, he received 8,723 shares through the exercise of restricted stock units at no cost. The company has disclosed new product development for quantum computing, a planned convertible debt offering, and a…
Indie Semiconductor Chief Executive Officer Donald McClymont sold 18,420 shares of Class A common stock on April 6, 2026, to satisfy withholding tax obligations tied to the vesting of restricted stock units. Earlier in the week he received 34,527 shares from RSU exercise at no cost. The company also disclosed a new ultraviolet laser diode for quant…
Indie Semiconductor's Chief Financial Officer, Wu Naixi, sold 5,876 Class A shares on April 6, 2026, for $17,547, while having exercised restricted stock units earlier in the month. The company also disclosed product and financing initiatives, and a strategic supply agreement with Mahindra & Mahindra Limited.
OmniAb, Inc. Director and CEO Matthew W. Foehr sold 19,244 shares on April 7, 2026, for about $28,673 at an average price of $1.49. The company reported fourth-quarter fiscal 2025 revenue of $8.4 million and a net loss of $14.2 million. Despite the financial shortfall, several analysts reiterated Buy or Outperform ratings, and InvestingPro data ind…
OmniAb Executive VP and CFO Kurt A. Gustafson sold 6,913 shares of company common stock on April 7, 2026 for approximately $10,300 at a weighted average price of $1.49. On the same day he exercised options that resulted in 13,542 newly issued shares, bringing his direct ownership to 261,483 shares. The disclosures come amid a quarter that saw falli…
OmniAb, Inc. (NASDAQ: OABI) Chief Legal Officer Charles S. Berkman sold 7,157 shares on April 7, 2026 for a total of $10,663, and that same day exercised options to acquire 13,542 shares tied to vested restricted stock units. The insider now directly holds 399,085 shares. The moves occurred as the stock traded at $1.51, after OmniAb reported a decl…
Ana G. Pinczuk, a member of SentinelOne, Inc.'s board, sold 16,042 shares of the company's Class A common stock on April 6, 2026, in a transaction valued at $215,123. The disposition - executed at $13.41 per share - was made to satisfy tax withholding tied to the vesting and settlement of restricted stock units. After the sale, Pinczuk retained dir…
Barry L. Padgett, President and Chief Operating Officer of SentinelOne, executed a company-mandated sale of 15,460 Class A shares on April 6, 2026, to satisfy tax-withholding obligations tied to restricted stock unit vesting. The trade generated $207,318 at $13.41 per share. SentinelOne, a cybersecurity firm valued at $4.58 billion, has seen its st…
TKO Group Holdings director Khan Nick sold 9,518 Class A shares on April 6, 2026, for about $1.89 million under a Rule 10b5-1 trading plan. The company has launched a $1 billion buyback program, announced a $0.78 quarterly dividend for Class A shareholders, and seen mixed analyst commentary amid new marketing partnerships and rights deals.
Arlo Technologies' Chief Financial Officer, Kurtis Joseph Binder, sold 25,000 shares on April 6, 2026, under a Rule 10b5-1 plan for about $349,640. The company recently delivered fourth-quarter 2025 results that outperformed analyst expectations on both EPS and revenue, and its board authorized a share repurchase program of up to $50 million runnin…
Acadia Pharmaceuticals executive vice president and CFO Mark C. Schneyer reported a sale of 2,709 shares on April 7, 2026, for $60,139. The disposition was filed on a Form 4. The company is contending with a negative opinion from the European Medicines Agency panel on its Rett syndrome candidate trofinetide, an analyst outlook that includes both an…
James Kihara, Principal Accounting Officer at Acadia Pharmaceuticals (ACAD), completed a sale of 1,030 shares on April 7, 2026, raising $22,866 to cover withholding taxes tied to vested restricted stock units. The trades were part of a structured compliance sale reported on Form 4 and followed an earlier option exercise. The company is concurrently…
ZipRecruiter Inc (NASDAQ: ZIP) Chief Executive Officer Ian H. Siegel reported two separate dispositions of Class A Common Stock in a Form 4 filing with the Securities and Exchange Commission. The transactions, executed under a Rule 10b5-1 trading plan, totaled $502,810 when combined with a prior charitable gift of shares. The stock has faced a stee…
Workday President Gerrit S. Kazmaier reported two recent stock dispositions in a Form 4 filing: a sale of 9,356 shares on April 7, 2026, for roughly $1.2 million and a separate disposal of 12,270 shares on April 5, 2026, to cover taxes on vested restricted stock units. The transactions leave Kazmaier with 165,074 Workday Class A shares directly hel…
Workday President and Chief Commercial Officer Robert Enslin completed a series of pre-arranged sales of Class A common shares in early April 2026 totaling approximately $695,338, while additional shares were withheld to satisfy tax obligations related to restricted stock units. The transactions occurred as Workday shares traded near a 52-week low …
SoftVest, LP, a holder of approximately 10% of Cross Timbers Royalty Trust (NYSE: CRT), executed two small purchases totaling $6,140 in early April, bringing its direct position to 711,325 units. The purchases were made at prices modestly below the trust's current market quote of $10.80, where the stock sits near its 52-week peak. An InvestingPro v…
Workday Inc. Chief Financial Officer Zane Rowe sold 5,990 shares of Class A common stock on April 7, 2026, for roughly $769,314 in multiple trades executed under a Rule 10b5-1 plan. He also sold 9,140 shares on April 5, 2026, to cover tax liabilities from restricted stock unit vesting. The company recently reported Q4 FY2026 results that met revenu…
David A. Duffield, a roughly 10% owner of Workday, sold about $13.9 million of Class A common stock on April 6, 2026, while converting a substantial block of Class B shares into Class A. The insider activity coincides with recent quarterly results that met revenue guidance and beat earnings, analyst price-target adjustments, and corporate moves inc…
Lipocine Inc. director John W. Higuchi purchased 40,000 shares on April 7, 2026, paying $2.03 per share for a total of $81,199, according to a Form 4 filing. The stock is trading close to its 52-week low after a steep pullback, while the company disclosed that its postpartum depression candidate LPCN 1154 did not meet the Phase 3 primary endpoint i…
Travere Therapeutics director Baynes Roy D. sold 10,000 shares on April 6, 2026, at $33.00 per share while exercising options to acquire 10,000 shares at $26.52. The company faces a three-month FDA review extension for its Filspari sNDA, moving the PDUFA date to April 13, 2026, and Stifel maintains a Hold rating with a $31.00 price target.
